| --- | --- | --- | |-------|-------|-------| | | | | | | | | | | | | | | | | Forward-looking statements 2 This document contains forward‐looking statements relating to the Company's strategy, objectives, business development plans and financial position. All statements other than statements of historical facts included in this document, including, without limitation, statements regarding the Company's future financial position, strategy, anticipated investments, costs and results, status and results of cli ...

Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) Q4 2019 Results Earnings Conference Call March 11, 2020 8:30 AM ET Company Participants Allison Wey - Senior Vice President of Investor Relations and Corporate Communications Paul Edick - Chairman & Chief Executive Officer Barry Deutsch - Chief Financial Officer Conference Call Participants Ami Fadia - Leerink Randall Stanicky - RBC Capital Markets David Amsellem - Piper Sandler Difei Yang - Mizuho Securities David Steinberg - Jefferies Operator Ladies and gentlemen ...